Feasibility Study of a Software Application for Detection and Monitoring of Attentional Deficits in Delirium
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Delirium
- Sponsor
- University of Edinburgh
- Enrollment
- 48
- Primary Endpoint
- Semi-structured interviews with clinicians and patients to produce a set of recommendations to refine and optimise the DelApp.
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
This qualitative study aims to evaluate the usability of a smartphone application called DelApp. The study will assess usability and acceptability of the software app by asking 40 clinicians to administer the DelApp assessment to consented patient and clinicians. Feedback will be collected through semi-structured interviews with the clinicians. The feedback will be used to optimise the software application in preparation for formal validations studies.
Detailed Description
Delirium is an acute, serious syndrome involving abnormalities in attention, arousal and cognition. Delirium affects 1 in 8 hospital patients. Delirium is linked to a higher risk of death, increased length of stay, and substantial patient and carer distress. Despite its massive medical importance, delirium is grossly underdetected, with rates of formal detection of 20% or less. Investigators previously developed a new neuropsychological test for the objective measurement of inattention in delirium, implemented on a computerised device (Delbox). A prototype software application for smartphones (DelApp) has been developed based on the 'Delbox' tests. Findings from two pilot studies suggest that the DelApp performs well as a method for objectively measuring attention in delirium. As part of a new programme of work on attentional tests for delirium, formally funded by the Medical Research Council (grant value £1.01M), investigators plan further studies to refine the DelApp before conducting larger scale formal studies. The reasons for doing these additional studies are to: (1) shorten the duration of the DelApp assessment; (2) ask end users (i.e. clinicians) to evaluate the user interface; (3) gather feedback from end users regarding the ease of use of the test; and any other feedback from clinicians and patients; and finally (4) develop the DelApp software application further based on user feedback. Here investigators propose a preliminary qualitative study to evaluate feasibility of the optimised DelApp test (points 2 and 3). Investigators will assess usability and acceptability by asking 40 clinical staff to administer the DelApp test to consented patients (N=10) and colleagues (approximately N=30). Feedback will be collected from clinicians and patients through semi-structured interviews. The outcomes of this feasibility study will make further optimisation of the app possible, in preparation for formal validation studies.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Native or fluent English speaker
- •Capacity to give consent to participate in the study
- •Aged 65 or over
Exclusion Criteria
- •Vision, hearing or speech impairment severe enough to preclude testing and interview.
- •Known or suspected cognitive impairment including dementia
- •Photosensitive epilepsy
Outcomes
Primary Outcomes
Semi-structured interviews with clinicians and patients to produce a set of recommendations to refine and optimise the DelApp.
Time Frame: Baseline
Clinicians and patients who have used the DelApp will be interviewed using semi structured interviews.
Secondary Outcomes
- System usability scale to measure the usability of the DelApp.(Baseline)